G D Braatvedt
Affiliation: University of Auckland
Country: New Zealand
- Understanding the new HbA1c units for the diagnosis of Type 2 diabetesGeoff D Braatvedt
Department of Medicine, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
N Z Med J 125:70-80. 2012..For patients whose HbA1c is less than and equal to 40 mmol/mol, repeat screening (including for CVD risk) at intermittent intervals is recommended as per published guidelines...
- Risk factors for recurrent diabetic ketoacidosisG Braatvedt
Department of Medicine, Auckland Hospital
Diabet Med . 2016..This article is protected by copyright. All rights reserved...
- Glucose control peri-myocardial infarctionG D Braatvedt
Department of Medicine and Endocrinology, University of Auckland, Auckland, New Zealand
Intern Med J 38:341-4. 2008..The results of these studies are inconclusive with no clear evidence that this intervention has additional benefit over and above routine care...
- Metabolic characteristics of patients with apparently normal fasting plasma glucoseGeoff Braatvedt
Department of Medicine, University of Auckland Auckland City Hospital, Auckland
N Z Med J 119:U2123. 2006..To describe the prevalence of dysglycaemia in patients with fasting glucose <6.1 mmol/L...
- Current and former smoking increases mortality in patients on peritoneal dialysisGeoffrey D Braatvedt
Department of Medicine, University of Auckland, Auckland, New Zealand
N Z Med J 119:U1977. 2006..There is limited information on the effects of smoking behaviour on mortality in patients with end-stage renal failure (ESRF). This study aimed to assess the interaction of smoking on death rate in patients with renal failure on dialysis...
- The effect of atorvastatin on markers of bone turnover in patients with type 2 diabetesG D Braatvedt
University Department of Medicine, Auckland Hospital, University of Auckland, Auckland, New Zealand
Bone 35:766-70. 2004..We conclude that atorvastatin (40 mg/day) has no significant effect on bone turnover in man...
- Bone mineral density in patients with treated Addison's diseaseG D Braatvedt
Department of Medicine, University of Auckland, Private Bag, Auckland, New Zealand
Osteoporos Int 10:435-40. 1999..Unexpected hypogonadism in men with Addison's disease is common...
- Outcome of managing impotence in clinical practiceG D Braatvedt
Medical Specialist Group, Mercy Specialist Centre, Auckland
N Z Med J 112:272-4. 1999..This study aims to describe the clinical course of consecutive, unselected men referred to a specialist endocrinology private practice with a primary diagnosis of impotence...
- The effect of acute hyperglycaemia on brachial artery flow mediated dilatation in normal volunteersW Bagg
Department of Medicine, University of Auckland, Auckland Hospital, Grafton, NZ
Aust N Z J Med 30:344-50. 2000..Endothelial function is known to be abnormal in patients with diabetes and acute hyperglycaemia may play an aetiological role...
- Effects of improved glycaemic control on endothelial function in patients with type 2 diabetesW Bagg
Division of Medicine, Auckland Hospital, Grafton, New Zealand
Intern Med J 31:322-8. 2001..Patients with type 2 diabetes have abnormal endothelial function but it is not certain whether improvements in glycaemic control will improve endothelial function...
- The influences of obesity and glycemic control on endothelial activation in patients with type 2 diabetesW Bagg
Department of Medicine, University of Auckland, 1000 Auckland, New Zealand
J Clin Endocrinol Metab 86:5491-7. 2001..Obesity appears to be the most important predictor of endothelial activation in patients with type 2 diabetes. Short-term improvement in glycemic control does not appear to reduce endothelial activation...
- The effects of intensive glycaemic control on body composition in patients with type 2 diabetesW Bagg
Department of Medicine, University of Auckland, New Zealand
Diabetes Obes Metab 3:410-6. 2001..To examine the effects of improved glycaemic control over 20 weeks on the type and distribution of weight change in patients with type 2 diabetes who at baseline have poor glycaemic control...